Mikael Dolsten appointed visiting professor at Lund University
This article is over 5 years old, and the information may therefore be outdated. Mikael Dolsten, head of research at Pfizer, who led the development of Pfizer’s and BioNTech’s Covid-19 vaccine, will take up the appointment of visiting professor of Pharmacology at Lund University in Sweden on 1 January 2021. “During my years as a student and researcher in Lund I had many mentors who inspired me. I
https://www.medicine.lu.se/article/mikael-dolsten-appointed-visiting-professor-lund-university - 2026-05-05
